MediWound Ltd.

MDWD | NASDAQ

Price Alert Chart Builder DCF Calculator

$13.31

-$0.09 (-0.67%)

At close: Sep 21, 2026, 4:00 PM ET

$13.52

+$0.21 (+1.58%)

Pre-market: Sep 22, 2026, 8:01 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.67%

(1D)

Rating

Updated: Sep 18, 2026

20.2

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $170.98M

1D Range

13.12 13.42

52W Range

12.52 20.03

Valuation (TTM)

PE -8.32

PB 4.80

EV/EBITDA -7.64

Valuation (NTM)

Forward PE N/A

Forward PEG -26.81

Price Target $28.50

Cash Flow

FCF Yield -16.6%

SBC Adj. FCF Yield -17.8%

SBC Impact -7.2%

Margins

Gross Margin 15.5%

Operating Margin -267.9%

FCF Margin -239.3%

Growth (CAGR)

Revenue 3Y | 5Y -23.0% | -14.0%

Dil EPS 3Y | 5Y 13.1% | 15.8%

FCF 3Y | 5Y -14.6% | -19.2%

Returns

ROA -28.1%

ROE -47.2%

ROIC -58.5%

Financial Health

Net Cash

$34.41M

Current Ratio 2.32

Interest Coverage -28.35

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germ...

Sector Healthcare

Industry Biotechnology

Employees 121

IPO Date Mar 19, 2014

Website www.mediwound.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 19, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$28.50

Upside

+114.12%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞